Genenta Science S.p.A. (NASDAQ:GNTA – Get Free Report) saw a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 3,300 shares, a decline of 5.7% from the February 29th total of 3,500 shares. Based on an average daily volume of 4,100 shares, the short-interest ratio […]
Genenta Science (GNTA) Demonstrates Reprogramming of the Tumor Microenvironment in GBM Patients streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Glioma Clinical Trial Pipeline Insights | 200+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Head-To-Head Review: Acumen Pharmaceuticals (NASDAQ:ABOS) and Genenta Science (NASDAQ:GNTA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.